Basilea Pharmaceutica Ltd logo

Basilea Pharmaceutica Ltd

XSWX:BSLN (Switzerland)  
CHF 41.95 (+0.6%) Apr 18
Market Cap:
CHF 503.54M ($ 554.86M)
Enterprise V:
CHF 572.24M ($ 630.57M)
Volume:
37.12K
Avg Vol (2M):
39.13K
Also Trade In:
Volume:
37.12K
Avg Vol (2M):
39.13K
Market Cap CHF M 503.54
Enterprise Value CHF M 572.24
P/E(ttm) 66.59
PE Ratio without NRI 66.59
Forward PE Ratio 20.33
Price/Book --
Price/Sales 3.43
Price/Free Cash Flow 48.22
Price/Owner Earnings 92.14
Payout Ratio % --
Revenue (TTM) CHF M 157.00
EPS (TTM) CHF 0.63
Beneish M-Score -3.03
10-y EBITDA Growth Rate % --
5-y EBITDA Growth Rate % --
y-y EBITDA Growth Rate % -0.80
EV-to-EBIT 26.41
EV-to-EBITDA 24.63
PEG --
Shares Outstanding M 12.00
Net Margin (%) 6.63
Operating Margin % 13.90
Pre-tax Margin (%) 6.64
Quick Ratio 2.64
Current Ratio 3.20
ROA % (ttm) 5.02
ROE % (ttm) 10,000.00
ROIC % (ttm) 17.22
Dividend Yield % --
Altman Z-Score -4.45
Piotroski F-Score 6.00
Positive ROA Y
Positive CFROA Y
Higher ROA y-y N
Cash flow > Earnings Y
Lower Leverage y-y Y
Higher Current Ratio y-y Y
Less Shares Outstanding y-y N
Gross Margin Increase y-y N
Higher Asset Turnover y-y Y

XSWX:BSLN Number of Guru Trades

To

XSWX:BSLN Volume of Guru Trades

To

Gurus Latest Trades with XSWX:BSLN

No Available Data

XSWX:BSLN is held by these investors

No Available Data